The IMPACT Knockout A-549 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the A-549 human lung adenocarcinoma line, featuring targeted disruption of the IMPACT gene. This product provides researchers with a genetically heterogeneous loss-of-function model to interrogate IMPACT-dependent mechanisms in stress signaling and translational control. The polyclonal format preserves diverse editing outcomes across the cell pool, enabling robust assessment of gene function in cancer biology and integrated stress response pathways without clonal selection artifacts.
The A-549 host cell line is an adherent alveolar basal epithelial adenocarcinoma model originally established from a 58-year-old Caucasian male with lung carcinoma. A-549 cells are widely employed in cancer research for studying tumor cell biology, drug sensitivity, and stress adaptation. Their epithelial origin and tumorigenic background render them particularly suitable for investigating how IMPACT-mediated regulation of the integrated stress response influences survival, proliferation, and therapeutic resistance in lung adenocarcinoma contexts.
IMPACT encodes an inhibitor of GCN2 kinase, a key sensor of amino acid deprivation and other stresses. By binding GCN2 and suppressing its activity, IMPACT reduces phosphorylation of the translation initiation factor eIF2??. This attenuation limits the activation of the integrated stress response, consequently decreasing translation of ATF4 and downstream targets such as CHOP, GADD34, and PPP1R15A. Thus, under basal conditions, IMPACT functions as a tonic brake on GCN2-eIF2??-ATF4 signaling, modulating the threshold for stress-induced gene expression. Ribosome-associated proteins further interact with IMPACT to fine-tune this regulatory node.
Disrupting IMPACT in A-549 cells constitutively derepresses GCN2, leading to elevated eIF2?? phosphorylation and heightened stress pathway activity even in the absence of external stimuli. This model enables dissection of how constitutive stress signaling alters lung adenocarcinoma cell behavior, including changes in proliferation, metabolism, and vulnerability to proteotoxic or chemotherapeutic insults. Given the role of the integrated stress response in tumor adaptation, this knockout system is instrumental for probing the dual pro-survival and pro-death outputs downstream of eIF2??-ATF4 in cancer biology.
This polyclonal knockout cell pool supports a broad range of investigations, including western blotting for phospho-eIF2?? levels, RT-qPCR for ATF4 and CHOP transcripts, stress challenge assays with amino acid starvation or ER stressors, cell viability assays under chemotherapeutic pressure, and phospho-eIF2?? flow cytometry. Additionally, RNA-seq and ATF4 reporter assays enable transcriptome-wide and functional readouts of stress pathway engagement. For further information or to discuss custom uses, please contact Ascent Research.
